Cargando…
Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129123/ https://www.ncbi.nlm.nih.gov/pubmed/36939235 http://dx.doi.org/10.1097/CM9.0000000000002570 |
_version_ | 1785030661367660544 |
---|---|
author | Fu, Ruiying Liang, Yuanzheng Wei, Liqiang Liu, Xindi Piao, Yingshi Wang, Liang |
author_facet | Fu, Ruiying Liang, Yuanzheng Wei, Liqiang Liu, Xindi Piao, Yingshi Wang, Liang |
author_sort | Fu, Ruiying |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10129123 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101291232023-04-26 Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma Fu, Ruiying Liang, Yuanzheng Wei, Liqiang Liu, Xindi Piao, Yingshi Wang, Liang Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-03-20 2023-03-20 /pmc/articles/PMC10129123/ /pubmed/36939235 http://dx.doi.org/10.1097/CM9.0000000000002570 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Correspondence Fu, Ruiying Liang, Yuanzheng Wei, Liqiang Liu, Xindi Piao, Yingshi Wang, Liang Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma |
title | Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma |
title_full | Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma |
title_fullStr | Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma |
title_full_unstemmed | Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma |
title_short | Combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (GPED) in treatment of advanced extranodal NK/T-cell lymphoma |
title_sort | combination of gemcitabine, pegaspargase, etoposide, and dexamethasone (gped) in treatment of advanced extranodal nk/t-cell lymphoma |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129123/ https://www.ncbi.nlm.nih.gov/pubmed/36939235 http://dx.doi.org/10.1097/CM9.0000000000002570 |
work_keys_str_mv | AT furuiying combinationofgemcitabinepegaspargaseetoposideanddexamethasonegpedintreatmentofadvancedextranodalnktcelllymphoma AT liangyuanzheng combinationofgemcitabinepegaspargaseetoposideanddexamethasonegpedintreatmentofadvancedextranodalnktcelllymphoma AT weiliqiang combinationofgemcitabinepegaspargaseetoposideanddexamethasonegpedintreatmentofadvancedextranodalnktcelllymphoma AT liuxindi combinationofgemcitabinepegaspargaseetoposideanddexamethasonegpedintreatmentofadvancedextranodalnktcelllymphoma AT piaoyingshi combinationofgemcitabinepegaspargaseetoposideanddexamethasonegpedintreatmentofadvancedextranodalnktcelllymphoma AT wangliang combinationofgemcitabinepegaspargaseetoposideanddexamethasonegpedintreatmentofadvancedextranodalnktcelllymphoma |